Renal Cancer - Results from #4680

RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition February 8, 2018

Eosinophilic Solid and Cystic Renal Cell Carcinoma: Imaging Features of a Novel Neoplasm February 7, 2018

Advanced native-kidney carcinoma in a heart- and kidney-transplanted patient: a case report February 7, 2018

Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials February 7, 2018

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma February 7, 2018

A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1. February 6, 2018

Surgical management of renal cell carcinoma with levels III and IV tumor thrombus using the « flush » technique. February 6, 2018

MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1 February 5, 2018

Efficacy and Tolerability of Bacillus Calmette-Guérin Therapy as the First-Line Therapy for Upper Urinary Tract Carcinoma In Situ. February 5, 2018

Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields February 2, 2018

Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 27 cases February 2, 2018

Overview of Current and Future First-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma February 2, 2018

[Laparoscopic transperitoneal partial nephrectomy for a tumor of the upper segment] February 1, 2018

[Results of open and laparoscopic partial nephrectomy for localized renal cancer] February 1, 2018

[Improving renal cancer care] February 1, 2018

Positive surgical margins are predictors of local recurrence in conservative kidney surgery for pT1 tumors January 31, 2018

Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond January 31, 2018

Immune biomarkers predictive for disease-free survival with adjuvant sunitinib in high-risk locoregional renal cell carcinoma: from randomized phase III S-TRAC study. January 30, 2018

Risk-based surveillance after surgical treatment of renal cell carcinoma January 30, 2018

Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial January 30, 2018

Page 235 of 458